Open-label, Parallel-group Study Evaluating the Pharmacokinetics of AMG 145 in Hepatic-impaired and Healthy Subjects

Sponsor ID

20120341

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1

Product

Evolocumab

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

Location

Status

Location

Research Site

Knoxville, TN, United States, 37920

Status

Recruiting

Location

Research Site

Miami, FL, United States, 33143

Status

Recruiting

Location

Research Site

Orlando, FL, United States, 32809

Status

Recruiting